Financials
Financial year 2025
Revenue
€ 42.9 million
▲ 6% vs 2023
Profit
Healthy€ 1.9 million
▼ 26% vs 2023
Debts
Low€ 21.9 million
▲ 173% vs 2023
MEDGENIX BENELUX from Wevelgem, company number BE0407171356, closed financial year 2025 with a result of € 1.9 million after tax. For that financial year MEDGENIX BENELUX recorded revenue of € 42.9 million and equity of € 17.5 million. Compared with financial year 2023, the result moved from € 2.6 million to € 1.9 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.
What happened at MEDGENIX BENELUX?
What happened at MEDGENIX BENELUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Geert Florizoone stepped down as director. NBB
- Magali Verbraeken stepped down as director. NBB
- Anja Van Winsberghe stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 1.9 million (▼ 26% vs 2023). Source: NBB ↗
- Geert Florizoone became a director. NBB
- Magali Verbraeken became a director. NBB
- Anja Van Winsberghe became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 1.5 million profit in 2021 to € 1.9 million profit in 2025.
Paid € 2.7 million in corporate taxes since 2021.
Best year ever: 2023, with € 2.6 million profit.
Paid out € 14.7 million in dividends to the owners in total.
A new publication or filing at MEDGENIX BENELUX? We notify you, reason included.
Follow MEDGENIX BENELUXNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
The shares are held by Perrigo Belgium NV (100%).
Directors
According to the 2025 annual accounts
Magali Verbraeken
Director
Also active at: OMEGA PHARMA TRADING, Perrigo Belgium, Perrigo Capital +5 more
since 2024 · until 2030
Anja Van Winsberghe
Director
Also active at: OMEGA PHARMA TRADING, Perrigo Belgium, Perrigo Capital +7 more
since 2020 · until 2026
Geert Florizoone
Director
since 2024 · until 2030
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Vliegveld 21
8560 Wevelgem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
NEDZONE-AS, NL
Website info
Features
Security
Details
- Company number
- 0407.171.356
- VAT number
- BE 0407.171.356
- Registered office
- Vliegveld 21, 8560 Wevelgem
- Names & denominations
- MEDGENIX BENELUX
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 21 June 1970
- Peppol
- Active · Active since 8 Dec 2025
- Contact
- medgenix.be
- Activities · NACE
Vervaardiging van geneesmiddelen
Vervaardiging van overige chemische producten
Vervaardiging van andere chemische producten, neg